Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.35% |
| 2 | Healthcare | 2.86% |
| 3 | Financials | 2.56% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 2.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12001
CALL
Direxion Daily Transportation Bull 3X ETF
TPOR
$21.1M
| $51.9K | ﹤0.01% |
+2,400
| New | +$55.3K |
|
|
SCNI
12002
Scinai Immunotherapeutics
SCNI
$1.27M
| $51.9K | ﹤0.01% |
+1,746
| New | +$131K |
|
12003
CALL
Finance of America Companies
FOA
$198M
| $51.8K | ﹤0.01% |
4,080
-270
| -6% | -$3.96K |
|
12004
FNB Corp
FNB
$6.75B
| $51.8K | ﹤0.01% |
3,970
-961,829
| -100% | -$12.9M |
|
12005
PUT
Evertec
EVTC
$1.78B
| $51.8K | ﹤0.01% |
+1,600
| New | +$52.6K |
|
12006
Genprex
GNPX
$2.16M
| $51.7K | ﹤0.01% |
+1
| New | +$56.5K |
|
12007
Jerash Holdings
JRSH
$63.5M
| $51.6K | ﹤0.01% |
+13,311
| New | +$55.8K |
|
12008
PUT
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.19B
| $51.6K | ﹤0.01% |
+2,300
| New | +$51.2K |
|
|
SHCR
12009
CALL
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $51.5K | ﹤0.01% |
32,200
+15,600
| +94% | +$28.9K |
|
|
STRM
12010
DELISTED
Streamline Health Solutions
STRM
| $51.5K | ﹤0.01% |
2,173
+1,175
| +118% | +$28.6K |
|
12011
CALL
CorMedix
CRMD
$584M
| $51.5K | ﹤0.01% |
12,200
-17,000
| -58% | -$60.1K |
|
12012
CALL
Akebia Therapeutics
AKBA
$252M
| $51.5K | ﹤0.01% |
89,200
+14,100
| +19% | +$4.42K |
|
12013
CALL
InflaRx
IFRX
$271M
| $51.5K | ﹤0.01% |
16,600
-13,900
| -46% | -$35.4K |
|
12014
PUT
NanoViricides
NNVC
$36.2M
| $51.4K | ﹤0.01% |
46,300
-400
| -0.9% | -$624 |
|
12015
PUT
SPS Commerce
SPSC
$2.64B
| $51.4K | ﹤0.01% |
+400
| New | +$51.5K |
|
12016
CALL
Atossa Therapeutics
ATOS
$23.5M
| $51.3K | ﹤0.01% |
6,473
-1,507
| -19% | -$17.3K |
|
|
SFE
12017
DELISTED
Safeguard Scientifics, Inc.
SFE
| $51.3K | ﹤0.01% |
+16,551
| New | +$55.6K |
|
12018
PUT
Absci
ABSI
$1.51B
| $51.2K | ﹤0.01% |
24,400
-32,600
| -57% | -$89.2K |
|
|
CANO
12019
PUT
DELISTED
Cano Health, Inc.
CANO
| $51.2K | ﹤0.01% |
374
-1,116
| -75% | -$378K |
|
12020
PUT
LifeMD
LFMD
$172M
| $51.2K | ﹤0.01% |
26,400
-3,600
| -12% | -$8.07K |
|
12021
CALL
Standex International
SXI
$4.12B
| $51.2K | ﹤0.01% |
+500
| New | +$49.1K |
|
12022
PharmaCyte Biotech
PMCB
$6.34M
| $51.1K | ﹤0.01% |
+17,503
| New | +$50.1K |
|
|
ENG
12023
DELISTED
ENGlobal Corp
ENG
| $51.1K | ﹤0.01% |
8,295
+5,229
| +171% | +$40.6K |
|
|
MRUS
12024
PUT
DELISTED
Merus
MRUS
| $51.1K | ﹤0.01% |
+3,300
| New | +$58.1K |
|
|
MRIN
12025
CALL
DELISTED
Marin Software
MRIN
| $51K | ﹤0.01% |
8,500
+117
| +1% | +$815 |
|
Similar funds
Citadel Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Citadel Advisors held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in Denbury Inc. worth $107M.
- Citadel Advisors's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Citadel Advisors added most to Tesla in Q4 2022, an estimated $913M increase.
- Citadel Advisors's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Citadel Advisors fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Citadel Advisors's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Citadel Advisors opened 3,614 new positions and closed 1,312 in Q4 2022.
- Citadel Advisors's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.